Blood lipid levels (Lipid profile)

Blood lipid levels refer to the concentration of various fatty substances, primarily cholesterol and triglycerides, circulating in the bloodstream as part of lipoprotein complexes. These lipids are fundamental to human physiology, serving as essential components of cell membranes, precursors for steroid hormones and bile acids, and as a major source of stored energy (StatPearls: Lipid Profile, 2023). While essential for life, imbalances in these levels—collectively known as dyslipidemia—are a primary driver of atherosclerotic plaque formation within arterial walls, leading to coronary artery disease, stroke, and peripheral vascular disease (NIH: High Blood Cholesterol, 2022). In the context of pharmacology, blood lipid levels are not a single molecular target but rather a composite clinical endpoint and biomarker used to measure the efficacy of various therapies. Drugs such as statins, PCSK9 inhibitors, and fibrates modulate these levels by interacting with specific proteins like HMG-CoA reductase or the LDL receptor (Mayo Clinic: Cholesterol Test, 2023). Monitoring the lipid profile is standard clinical practice for assessing cardiovascular risk and guiding the use of lipid-lowering agents to achieve specific therapeutic goals, such as lowering LDL-C to prevent major adverse cardiovascular events (AHA/ACC Guidelines, 2018).

Other names

Serum lipidsPlasma lipid levelsLipid panelCholesterol and triglycerides

Modulation of blood lipid levels is achieved through various mechanisms including: inhibition of HMG-CoA reductase to reduce cholesterol synthesis; inhibition of NPC1L1 to decrease intestinal cholesterol absorption; inhibition of PCSK9 to increase LDL receptor density on hepatocytes; activation of PPAR-alpha to increase fatty acid oxidation; and inhibition of ATP citrate lyase (ACL) to reduce substrate availability for cholesterol synthesis (StatPearls, 2023; NIH, 2022).